K-161 Ophthalmic Solution

· Kowa Research Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K-161 Ophthalmic Solution, covering 2025-01-14 to 2025-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease [Phase 3]

See pricing